Effect On Quality Of Life (Qol) Of Adding Cisplatin To Single-Agent Firstline Chemotherapy In Elderly Patients With Advanced Non-Small Cell Lung Cancer (Nsclc): A Joint Analysis Of The Multicentre, Randomized, Phase 3 Miles-3 And Miles-4 Studies

ANNALS OF ONCOLOGY(2017)

引用 1|浏览76
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要